UnknownNot Applicable

Study on Therapy of Non-invasive Prolactinoma

China394 participantsStarted 2016-01-01

Plain-language summary

the study aim to investigate the endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery treatment and Dopamine agonist treatment.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: non-invasive prolactionma Exclusion Criteria: invasive prolactioma

What they're measuring

Endocrine remission rate

Timeframe: five-year

Trial details

NCT IDNCT03353025

SponsorFirst Affiliated Hospital, Sun Yat-Sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Contact for this trial

Zongming Wang, Dr.

8613570903721 wzmyan@foxmail.com

View on ClinicalTrials.gov More Prolactinoma trials